Coagulopathy
72
6
6
36
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
4 terminated out of 72 trials
90.0%
+3.5% vs benchmark
13%
9 trials in Phase 3/4
19%
7 of 36 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 36 completed trials
Clinical Trials (72)
Assessment of Artificial Intelligence Algorithms for ROTEM
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
Association Between Hypomagnesemia and Coagulopathy in Sepsis
Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients
ROTEM Interpretation AI vs Experts
Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study
Microcirculation and Coagulopathy in Sepsis
Fibrinogen Early In Severe Trauma StudY II
Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage
Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy
Ascending Dose Study of FrontlineODP™ Spray Dried Plasma
Predictive Accuracy of PLR and PNR in Detecting ETIC
Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen
Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study
Transfusion Using Stored Whole Blood
Patient Blood Management Implementation in CEE Study
Evaluation of TEG 6S PM® During Cardiopulmonary Bypass to Detect Postoperative Biological Coagulopathy
Thrombelastography for Coagulopathy in Chinese Snakebites